1. MARKETS
  2. SECTOR : GENERAL & INDUSTRIAL MANUFACTURING
  3. INDUSTRY : INDUSTRIAL MACHINERY
  4. XYLEM INC
101.82-2.75(-2.63%)
2.5M
XNYS Volume

XNYS 07 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Xylem quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Xylem share price target, revenues, EPS, net income and more

Xylem quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Xylem Jun-2026 Quarterly Revenue is $2,336 Million which is growth of 1.5% YoY.

  • POSITIVE

    Quarterly Net Profit Xylem Jun-2026 Quarterly Net Profit is $263 Million which is growth of 16.4% YoY.

Xylem Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
2,3362,1252,3972,2682,3012,0692,2562,1042,1692,0332,1182,0761,722
Cost Of Rev.
1,3731,3221,4651,3851,4091,3011,3991,3201,3501,2811,3621,3121,071
Gross Profit
963803932883892768857784819752756764651
⌄
562528546526561516565500543533526552504
Operating Profit
401275386357331252292284276219230212147
-7-421-6-9-819-10-11-1414-14-12
Profit Before Tax
364244368297299217375269247196210185114
Tax
103553571755049525343-563322
⌄
26319333522722616932621719415326615292
Diluted NI Avail to Com Stockholders Ann.
26319333522722616932621719415326615292
Basic EPS
1.10.81.40.90.90.71.30.90.80.61.20.60.5
Diluted EPS After ExtraOrdinary
1.20.91.41.110.81.60.90.90.71.20.70.6
Number Of Shares End
236.3242.8243.6243.5243.4243.1242.9242.9242.6241.9241.2240.9205.5
Net Income Continuing Discontinued Operations
26319333522722616932621719415326615292
Normalized Income
282.4214350.4272.7245.5192.8382.5221.8211.3164.7281.8169.3114.7
Interest Income
-------------
Interest
7466989101114141412
Net Interest Income
-7-421-6-9-819-10-11-1414-14-12
EBIT
371248374303308225384279258210224199126
EBITDA
511388517445453370526420403344361346218
Reconciled Cost Of Rev.
1,3731,3221,4651,3851,4091,3011,3991,3201,3501,2811,3621,3121,071
Reconciled Depr.
14014014314214514514214114513413714792
Profit From Continuing Operations
26118933322222616932621719415326615292
Normalized EBITDA
538415534505479401591426425359381367246
*All financials are in USD Million and price data in USD

Xylem competitor comparison and performance snapshot within industry

Xylem annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue Xylem Dec-2025 Annual Revenue is $9,035 Million which is growth of 5.5% YoY.

  • POSITIVE

    Annual Net Profit Xylem Dec-2025 Annual Net Profit is $957 Million which is growth of 7.5% YoY.

Xylem Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
17.8%
13.1%
 9,0358,5627,3645,5225,1954,8765,2495,2074,7073,7713,653
Cost Of Rev. Ann.
17.4%
12.8%
5,5455,5605,3504,6473,4383,2203,0463,2033,1812,8562,3102,249
Gross Profit Ann.
18.6%
13.7%
3,5813,4753,2122,7172,0841,9751,8302,0462,0261,8511,4611,404
Operating Exp. Ann.
14.5%
10.1%
2,1622,1492,1411,9891,4331,3831,3301,3491,3501,2701,025949
Operating Profit Ann.
26.8%
21.5%
1,4191,3261,071728651592500697676581436455
-
-
4-2-16-21-34-69-70-62-78-79-68-53
Other Exp. Ann.
-
-
 -14332-72-177-12-145-219-13-36-281
PBT Ann.
39%
32.9%
1,2731,1811,087635440511285416585466340403
Tax Ann.
39.6%
49.4%
2642311972685843115361368063
⌄
39.2%
30.4%
1,018957890609355427254401549331260340
Diluted NI Avail to Com Stockholders Ann.
39.2%
30.4%
1,018957890609355427254401549331260340
EPS Ann.
24.9%
22.7%
 3.93.72.822.41.42.23.11.81.51.9
Diluted EPS Ann.
24.9%
22.7%
 3.93.72.822.41.42.231.81.51.9
Number Of Shares End
10.6%
6.2%
 243.6242.9241.2180.3180.4180.1180.3179.8179.6179.4179.1
Total Exp. Ann.
16.5%
12%
 7,7097,4916,6364,8714,6034,3764,5524,5314,1263,3353,198
Net Income Continuing Discontinued Operations Ann.
39.2%
30.4%
1,018957890609355427254401549331260340
Normalized Income Ann.
41.3%
23.4%
1,119.41,064.9978.5682.8377.6431.2372.5603.2569.7355.8283337.5
Interest Income Ann.
19.1%
31%
 272828167754322
Interest Ann.
-16.6%
-17.7%
232944495076776782827055
EBITDA Ann.
35%
23.8%
1,8611,7851,6931,120726832613740928782561591
Reconciled Cost Of Rev. Ann.
17.4%
12.8%
5,5455,5605,3504,6473,4383,2203,0463,2033,1812,8562,3102,249
Reconciled Depr. Ann.
34.6%
18%
565575562436236245251257261234151133
Profit From Continuing Operations Ann.
38.8%
30.2%
1,005950890609355427254401549330260340
Normalized EBITDA Ann.
36.5%
20.8%
1,9921,9191,8011,197754837746950950817591588
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
5.5%
2Y CAGR
10.8%
3Y CAGR
17.8%
5Y CAGR
13.1%
7Y CAGR
8.2%
10Y CAGR
9.5%
Total Revenue Annual growth is lower than historical averages.
Net Profit Ann.
1Y CHG
7.5%
2Y CAGR
25.4%
3Y CAGR
39.2%
5Y CAGR
30.4%
7Y CAGR
8.3%
10Y CAGR
10.9%
Net Profit Annual growth is lower than historical averages.
Operating Exp. Ann.
1Y CHG
0.4%
2Y CAGR
3.9%
3Y CAGR
14.5%
5Y CAGR
10.1%
7Y CAGR
6.9%
10Y CAGR
8.5%
Operating Expenses Annual Cr growth is lower than historical averages.

Xylem balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Xylem Dec-2025 Total Shareholders Fund is $11,480 Million which is growth of 7.9% YoY.

  • POSITIVE

    Total Assets Xylem Dec-2025 Total Assets is $17,634 Million which is growth of 6.9% YoY.

Xylem Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
30.4%
15%
17,63416,49316,1127,9528,2768,7507,7107,2226,8606,4744,657
⌄
9.8%
0.4%
5,8855,6115,9364,4495,0505,7744,7434,4404,3414,2672,573
⌄
48.7%
31.1%
11,48010,64210,1663,4943,2182,9682,9572,7682,5032,1902,084
Total Capitalization Ann.
33.9%
18.8%
12,88812,62012,4345,3745,6585,4524,9974,8194,7034,2983,280
Tangible Assets Ann.
-
-
87628350-155-590-979-1,056-1,440-1,433-1,64365
Working Capital Ann.
7.9%
2.6%
1,7851,7621,6791,4221,7691,5679497059716011,182
Invested Capital Ann.
35.7%
17.3%
13,42212,65812,4505,3745,6586,0525,2735,0764,7034,5583,358
Tangible Book Value Ann.
-
-
87628350-155-590-979-1,056-1,440-1,433-1,64365
Borrowings Ann.
1.9%
-8.1%
2,0632,1252,3901,9492,5093,1472,3772,3082,2002,3681,274
Net Debt Ann.
-20.9%
-17.5%
4638951,2659361,0911,2091,5922,0121,7862,060594
Share Issued Ann.
9.9%
5.9%
259.9259.2257.6196195.6194.9193.9192.9192.3191.4190.2
Number Of Shares End
10.6%
6.2%
243.6242.9241.2180.3180.4180.1180.3179.8179.6179.4179.1
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
6.9%
2Y CAGR
4.6%
3Y CAGR
30.4%
5Y CAGR
15%
7Y CAGR
13.6%
10Y CAGR
14.2%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
22.3%
2Y CAGR
13.8%
3Y CAGR
21.6%
5Y CAGR
7.9%
7Y CAGR
10.8%
10Y CAGR
13.2%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
7.9%
2Y CAGR
6.3%
3Y CAGR
48.7%
5Y CAGR
31.1%
7Y CAGR
22.5%
10Y CAGR
18.6%
Total ShareHolders Funds Annual growth is lower than historical averages.

Xylem ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share Xylem Book Value Per Share is $45 which is growth of -1.9% YoY.

  • NEUTRAL

    ROE Xylem ROE is 0% which is growth of 0% YoY.

Xylem Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
-5.46%5.06%4.38%5.02%3.09%5.37%7.80%4.96%4.67%7.14%
ROE Ann. %
-
-
-8.55%8.92%10.58%13.81%8.57%14.01%20.83%14.11%12.17%16.15%
ROIC %
-
-
-2.62.22.92.22.82.44.71.81.63.8
OPM Ann. %
7.6%
7.4%
14.68%12.51%9.89%11.79%11.40%10.25%13.28%12.98%12.34%11.56%12.46%
Inventory Turnover Ratio Ann.
-
-
-5.35.14.65.15.65.75.75.54.84.9
Asset Turnover Ann. %
-
-
-0.50.60.70.60.60.70.70.70.70.8
Working Capital Turnover Ann.
9.4%
10.5%
5.14.94.43.92.93.15.57.44.96.33.1
Quick Ratio Ann.
-
-
-1.21.21.31.71.41.211.30.91.7
Current Ratio Ann.
-
-
-1.81.81.92.31.81.61.51.91.52.4
Interest Coverage Ratio Ann.
-
-
-25.7149.87.74.77.28.16.75.98.3
LT Debt To Equity Ann.
-
-
-0.20.20.50.80.80.70.70.910.6
*All financials are in USD Million and price data in USD

Xylem cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Xylem Dec-2025 Cash From Operating Activity is $1,241 Million which is growth of -1.7% YoY.

  • POSITIVE

    Net Cash Flow Xylem Dec-2025 Net Cash Flow is $269 Million which is growth of 62.0% YoY.

Xylem Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
27.7%
8.5%
1,2411,263837596538824839586686497464
-
-
-471-482-628-191-183-169-231-643-181-1,886-132
-
-
-501-615-157-790-855473-177-40-4211,034-262
Cash Plus Cash Eqv. End Of Year Ann.
16.1%
-4.6%
1,4791,1211,0199441,3491,875724296414308680
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-24.9%
26916652-385-5001,128431-9784-35570
Cash Plus Cash Eqv. Begin Of Year Ann.
-6%
9.1%
1,1211,0199441,3491,875724296414308680663
Income Tax Paid Supplemental Data Ann.
43.2%
45.5%
26721921191834110775577875
Interest Paid Supplemental Data Ann.
-7.1%
-4.6%
6167697699777778784952
Capex Ann.
-
-
-331-321-271-208-208-183-226-237-170-124-117
Issuance Of Capital Stock Ann.
-
-
-----------
Issuance Of Debt Ann.
-
-76.3%
112781,3442813361,814-
Repayment Of Debt Ann.
-
-
-82-285-160-527-600-640-254-172-282-688-3
Repurchase Of Capital Stock Ann.
-
-
-15-20-25-52-68-61-40-59-25-4-179
Free Cash Flow Ann.
32.9%
7.3%
910942566388330641613349516373347
*All financials are in USD Million and price data in USD
Cash from Operating Act. Ann.
1Y CHG
-1.7%
2Y CAGR
21.8%
3Y CAGR
27.7%
5Y CAGR
8.5%
7Y CAGR
11.3%
10Y CAGR
10.3%
Cash from Operating Activity Annual is falling faster than historical averages.